ULBI
Ultralife Corporation
5.70$
+1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +133.3% | -10.5% | -5.0% | +49.7% | -127.3% | – | -80.1% | -129.2% | – | +762.4% | -33.9% | |
| – | -23.0% | +1,060.0% | -11.0% | -2.4% | +15.9% | +6.9% | +20.6% | +26.0% | -12.3% | +6.3% | +32.3% | |
| – | -43.1% | +24.3% | -8.0% | +36.3% | -15.4% | +25.2% | -28.8% | +15.6% | -32.0% | +32.2% | +34.0% | |
| – | -38.1% | -14.7% | -220.1% | – | – | -62.5% | -28.3% | – | – | – | – | |
| – | +90.7% | -73.9% | -453.4% | – | -1,155.6% | – | -96.9% | -1,505.2% | – | – | -84.5% | |
| – | +76.0% | -58.1% | +14.2% | +200.6% | +50.1% | -50.6% | -9.3% | -40.3% | +52.0% | -24.3% | +100.4% | |
| – | +110.1% | +278.4% | -87.4% | +200.6% | +653.4% | -90.5% | +783.4% | -93.6% | +52.0% | +1,857.4% | -92.2% | |
| – | – | – | – | – | – | -84.1% | +68.9% | -94.0% | – | – | – | |
| – | +1,132.0% | -93.5% | -95.7% | +2,753.8% | +163.7% | -95.4% | +64.4% | -89.9% | -46.7% | – | – | |
| – | – | – | +0.0% | +0.0% | -0.9% | -192.3% | – | -97.3% | +722.1% | +588.3% | -116.2% | |
| – | +1,080.8% | -98.0% | – | -16.7% | +1,280.5% | -197.3% | – | -97.4% | +959.8% | +443.9% | -115.7% | |
| – | -301.7% | – | – | -0.1% | -343.7% | – | -169.0% | – | – | -175.0% | – | |
| – | +180.4% | +14.1% | -8.6% | +14.0% | -238.1% | – | -91.9% | -294.7% | – | – | -51.6% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.